BCG trials to see if it's a shield against Covid-19 not just a shot in the dark - Prof Andreas Diacon

Stellenbosch University Professor Andreas Diacon is launching a 500-person clinical trial aimed to determine whether the BCG vaccines are indeed a shield against Covid-19. The trial involves revaccination of BCG that's been universally applied in South Africa since 1973. Numerous reports have pointed out a correlation between infection rates for countries where BCG is universally administered as being far lower than in those countries like the USA, Italy and Belgium where it was never used. There must be some degree of evidence that it might actually work to warrant the experiments. Hope springs! - Editor